128 related articles for article (PubMed ID: 8374878)
21. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.
Ljungberg B; Alamdari FI; Rasmuson T; Roos G
BJU Int; 1999 Sep; 84(4):405-11. PubMed ID: 10468753
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
[TBL] [Abstract][Full Text] [Related]
23. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
24. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases.
Grignon DJ; Ayala AG; el-Naggar A; Wishnow KI; Ro JY; Swanson DA; McLemore D; Giacco GG; Guinee VF
Cancer; 1989 Nov; 64(10):2133-40. PubMed ID: 2804902
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
[TBL] [Abstract][Full Text] [Related]
27. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma.
Al-Abadi H; Nagel R
Eur Urol; 1988; 15(3-4):271-6. PubMed ID: 3215262
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
[TBL] [Abstract][Full Text] [Related]
29. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
30. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
31. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
[TBL] [Abstract][Full Text] [Related]
32. Squamous cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry.
Nativ O; Winkler HZ; Reiman HM; Lieber MM
J Urol; 1990 Jul; 144(1):23-6. PubMed ID: 2359174
[TBL] [Abstract][Full Text] [Related]
33. Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry.
Ljungberg B; Larsson P; Roos G; Stenling R; Wilson G
J Urol; 1994 Jun; 151(6):1509-13. PubMed ID: 8189558
[TBL] [Abstract][Full Text] [Related]
34. Image analysis in the determination of ploidy and prognosis in renal cell carcinoma.
Lanigan DJ; McLean PA; Murphy DM; Donovan MG; Leader M
Eur Urol; 1992; 22(3):228-34. PubMed ID: 1468480
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.
Basting R; Corvin S; Händel D; Hinke A; Schmidt D
Anticancer Res; 1999; 19(2C):1493-5. PubMed ID: 10365130
[TBL] [Abstract][Full Text] [Related]
36. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of microvascular invasion in localized renal cell carcinoma.
Sevinç M; Kirkali Z; Yörükoğlu K; Mungan U; Sade M
Eur Urol; 2000 Dec; 38(6):728-33. PubMed ID: 11111192
[TBL] [Abstract][Full Text] [Related]
38. Ploidy and prognosis in renal carcinoma.
Lanigan D; McLean PA; Murphy DM; Donovan MG; Curran B; Leader M
Br J Urol; 1993 Jan; 71(1):21-4. PubMed ID: 8435731
[TBL] [Abstract][Full Text] [Related]
39. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]